| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.089 | 0.007 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.008 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.009 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.009 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.32 | 0.01 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.15 | 0.01 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.01 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |